Yang, Shenmiao
Huang, Haiwen
Zhou, Keshu
Zhao, Xielan
Han, Yanqiu
Li, Lindong
Wang, Yujie
Liu, Xiaofeng
Li, Jianyong
Article History
Received: 29 April 2024
Accepted: 26 August 2024
First Online: 14 September 2024
Declarations
:
: An institutional review board and independent ethics committee reviewed and approved the protocol before study initiation. The study was conducted according to the principles from international guidelines including the Declaration of Helsinki, Council for International Organizations of Medical Sciences International Ethical Guidelines, and applicable International Conference on Harmonization Good Clinical Practice guidelines.
: All patients provided written informed consent.
: Shenmiao Yang: Nothing to disclose.Haiwen Huang: Nothing to disclose.Keshu Zhou: Nothing to disclose.Xielan Zhao: Nothing to disclose.Yanqiu Han: Nothing to disclose.Lindong Li: Employment: AstraZeneca.Yujie Wang: Employment: AstraZeneca.Xiaofeng Liu: Employment: AstraZeneca.Jianyong Li: Nothing to disclose.